1. Home
  2. GMED vs CHE Comparison

GMED vs CHE Comparison

Compare GMED & CHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GMED
  • CHE
  • Stock Information
  • Founded
  • GMED 2003
  • CHE 1970
  • Country
  • GMED United States
  • CHE United States
  • Employees
  • GMED N/A
  • CHE N/A
  • Industry
  • GMED Medical/Dental Instruments
  • CHE Medical/Nursing Services
  • Sector
  • GMED Health Care
  • CHE Health Care
  • Exchange
  • GMED Nasdaq
  • CHE Nasdaq
  • Market Cap
  • GMED 7.6B
  • CHE 8.0B
  • IPO Year
  • GMED 2012
  • CHE N/A
  • Fundamental
  • Price
  • GMED $60.47
  • CHE $434.59
  • Analyst Decision
  • GMED Buy
  • CHE Strong Buy
  • Analyst Count
  • GMED 13
  • CHE 4
  • Target Price
  • GMED $87.30
  • CHE $578.50
  • AVG Volume (30 Days)
  • GMED 1.5M
  • CHE 199.2K
  • Earning Date
  • GMED 11-04-2025
  • CHE 10-28-2025
  • Dividend Yield
  • GMED N/A
  • CHE 0.55%
  • EPS Growth
  • GMED 745.36
  • CHE N/A
  • EPS
  • GMED 2.57
  • CHE 19.48
  • Revenue
  • GMED $2,626,461,000.00
  • CHE $2,511,915,000.00
  • Revenue This Year
  • GMED $15.62
  • CHE $5.91
  • Revenue Next Year
  • GMED $8.00
  • CHE $6.72
  • P/E Ratio
  • GMED $23.48
  • CHE $22.33
  • Revenue Growth
  • GMED 17.43
  • CHE 7.55
  • 52 Week Low
  • GMED $51.79
  • CHE $408.42
  • 52 Week High
  • GMED $94.93
  • CHE $623.61
  • Technical
  • Relative Strength Index (RSI)
  • GMED 57.69
  • CHE 40.93
  • Support Level
  • GMED $59.18
  • CHE $431.08
  • Resistance Level
  • GMED $61.64
  • CHE $462.94
  • Average True Range (ATR)
  • GMED 1.53
  • CHE 9.89
  • MACD
  • GMED 0.45
  • CHE -1.93
  • Stochastic Oscillator
  • GMED 79.25
  • CHE 18.25

About GMED Globus Medical Inc.

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

About CHE Chemed Corp

Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. Through its subsidiaries, the company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.

Share on Social Networks: